Cervimark


Public lists: Medical Devices (6123)

Cervimark is a medical diagnostics company that is developing a screening test for the prediction of pregnancies at high risk for preterm delivery. The test is based on quantifying biomarkers found in secretions of pregnant patients and correlating the resulting data to risk of pre-term labor. Proof of concept for this test has been demonstrated in a small human trial.

Cervimark is a medical diagnostics company that is developing a screening test for the prediction of pregnancies at high risk for preterm delivery. The test is based on quantifying biomarkers found in secretions of pregnant patients and correlating t...Show all

Company (Alive / Active)

Phone:

Fax:

St. Louis, 63141
Missouri, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cervimark $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cervimark Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Cellpoint Diagnostics

La Jolla, California, United States
Alive / ActiveCellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.Login to see details

Exagen Diagnostics

Vista, California, United States
Alive / ActiveExagen Diagnostics is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, the company's Avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)